TY - JOUR T1 - Evaluation of a disease-specific mHealth-based exercise self-tracking measure JF - medRxiv DO - 10.1101/2022.05.16.22275170 SP - 2022.05.16.22275170 AU - Ipek Ensari AU - Emma Horan AU - Noémie Elhadad AU - Suzanne R. Bakken Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/05/17/2022.05.16.22275170.abstract N2 - Objectives This study investigates the concurrent and construct validity of a brief, customizable exercise self-tracking item from a research mHealth App (“Phendo”) for use as a measure of day-level and habitual exercise behavior in endometriosis.Study Sample Study 1 included 52 participants who were recruited online and provided data for up to 14 days. Study 2 included 359 Phendo users who had retrospectively-collected data on the study measures.Methods In Study 1, we evaluated the responses on the self-tracking exercise item as estimates of day-level moderate-to-vigorous intensity exercise (MVE) and total step counts. Comparison measures included recall-based MVE minutes and accelerometry-based step counts, which were self-reported through daily surveys. In Study 2, we derived a measure of habitual exercise using each individual’s longitudinal self-tracked responses. We assessed its concurrent validity using the Nurses’ Health Study II Physical Activity Scale (NHS-II) as the comparison measure. We assessed its discriminant validity through known-group differences analysis where the sample was dichotomized based on Health Survey Short Form-36 (SF-36) and body mass index (BMI).Data Analysis We assessed bivariate associations between the scores on the self-tracking and comparison measures using Kendall’s rank correlations. We estimated daily MVE and step counts (Study 1), and weekly exercise (Study 2) from the self-tracking item scores through adjusted linear and polynomial regression models. We used t-tests and linear regression to conduct known-group differences analyses.Results In Study 1, self-tracked exercise responses were moderately correlated with survey based MVE and step counts. Regression analyses indicated that overall exercise responses were associated with ∼17 minutes of MVE for the average participant (B=16.09, t=3.11, p=0.045). Self-tracked aerobic-type exercise was a stronger predictor of MVE minutes and step counts (B=27.561, t=5.561, p<0.0001). In Study 2, each self-tracked exercise instance corresponded to ∼19 minutes of exercise per week on the NHS-II Scale (B=19.80, t=2.1, p=0.028). Finally, there were statistically significant differences between the groups dichotomized based on SF-36 subscale scores and BMI.Conclusion This study presents preliminary evidence on the concurrent and discriminant validity of a brief mHealth App measure for exercise self-tracking among individuals with endometriosis. These findings have implications in the context of large-scale studies that involve monitoring a diverse group of participants over long durations of time, as well as engaging and retaining research participants.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding for the work is provided by a postdoctoral fellowship from the Data Science Institute at Columbia University and an award from the National Library of Medicine (R01 LM013043).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All procedures were approved by Columbia University Irving Medical Center Institutional Review Board (Protocol #AAAQ9812) and all participants provided informed consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data produced in the present study are available upon reasonable request to the authors. ER -